Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-08-31Clinical Trial Update: Safety, Pharmacokinetics and Efficacy of FMX114 Versus Vehicle in Adults With Atopic Dermatitis [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating FMX114 vs vehicle in adults with atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2022-08-29Clinical Trial Update: Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1) [Phase 3]
Phase 3 trial evaluating lebrikizumab for moderate to severe atopic dermatitis completed; results posted.
-
CLINICAL_TRIALS trial_result · 2022-08-26Clinical Trial Update: Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis [Phase 2]
Phase 2 trial evaluating PF-07038124 ointment for atopic dermatitis and plaque psoriasis; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-07-28Clinical Trial Update: Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to <6 Years With Moderate-to-Severe Atopic Dermatitis (Liberty AD PRESCHOOL) [Phase 2, Phase 3]
Clinical trial update on safety, pharmacokinetics, and efficacy of dupilumab in children 6 months to under 6 years with moderate-to-severe a…
-
FDA approval · 2022-07-27FDA Approved: ADBRY — Supplemental Application (LEO Pharma Inc.)
FDA approved a supplemental application for Adbry (tralokinumab-ldrm) from LEO Pharma Inc. The approval results in updated labeling for the …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-07-22Clinical Trial Update: Efficacy of Fecal Microbial Transplantation Treatment in Adults With Atopic Dermatitis [Phase 3]
Phase 3 trial update reporting efficacy of fecal microbial transplantation for adults with atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2022-07-22Clinical Trial Update: Dupilumab Skin Barrier Function Study in Atopic Dermatitis [Phase 4]
Phase 4 clinical trial update shows completed study evaluating dupilumab's effect on skin barrier function in atopic dermatitis, with result…
-
CLINICAL_TRIALS trial_result · 2022-07-19Clinical Trial Update: Study of TER-101 Topical Ointment in Subjects With Atopic Dermatitis [Phase 2]
Phase 2 trial of TER-101 topical ointment for atopic dermatitis completed; results posted.
-
CLINICAL_TRIALS trial_result · 2022-07-19Clinical Trial Update: Response of Children With Atopic Dermatitis (Eczema) to Eucrisa [Phase 4]
Phase 4 trial update evaluating response of children with atopic dermatitis (eczema) to Eucrisa.
-
CLINICAL_TRIALS trial_result · 2022-07-18Clinical Trial Update: Safety Study of Tezepelumab (AMG 157) in Healthy Adults and Adults With Atopic Dermatitis [Phase 1]
Phase 1 safety trial of tezepelumab (AMG 157) in healthy adults and adults with atopic dermatitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-07-14Clinical Trial Update: Identification of Allergic Asthmatics Reactive to Felis Catus (Cat Hair) Allergen Inhalation [EARLY_Phase 1]
Early Phase 1 trial updating on identification of allergic asthmatics reactive to cat hair allergen; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2022-07-08Clinical Trial Update: Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy [Phase 3]
Phase 3 trial comparing abrocitinib to dupilumab in adults with moderate-to-severe atopic dermatitis on topical therapy has completed with r…
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis [Phase 3]
Long-term Phase 3 study assessing the safety and efficacy of baricitinib (LY3009104) for atopic dermatitis. The trial has completed and resu…
-
CLINICAL_TRIALS trial_result · 2022-06-28Clinical Trial Update: Phase 2b Study to Evaluate the Efficacy and Safety of ISB 830 in Adults With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2b trial evaluating ISB 830 for adults with moderate to severe atopic dermatitis has completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-06-24Clinical Trial Update: Moisturizer Mediated Prevention of Symptoms of Atopic Dermatitis in Early Childhood [Phase 3]
Phase 3 trial update investigating a moisturizer to prevent symptoms of atopic dermatitis in early childhood.
-
CLINICAL_TRIALS trial_result · 2022-06-22Clinical Trial Update: Evaluate the Efficacy of Using Modified Qing-Ying Decoction in Atopic Dermatitis Children [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating modified Qing-Ying Decoction for atopic dermatitis in children; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2022-06-10Clinical Trial Update: Efficacy, Safety, and Pharmacokinetic Profiles of REGN3500 Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis [Phase 2]
Phase 2 trial evaluating REGN3500 in adults with moderate-to-severe atopic dermatitis has been terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2022-06-09Clinical Trial Update: Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 study of Kyowa Kirin's anti-OX40 monoclonal antibody KHK4083 in moderate-to-severe atopic dermatitis completed with results posted.
-
FDA approval · 2022-05-31FDA Approved: FLUOCINOLONE ACETONIDE OIL — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for Fluocinonide Acetonide Oil from Rising Pharma Holdings, Inc., a topical corticosteroid produ…
-
CLINICAL_TRIALS trial_result · 2022-05-19Clinical Trial Update: Study Of PF-06817024 In Healthy Subjects, In Patients With Chronic Rhinosinusitis With Nasal Polyps And in Patients With Atopic Dermatitis [Phase 1]
A Phase 1 clinical trial evaluating PF-06817024 in healthy subjects, and in patients with chronic rhinosinusitis with nasal polyps and atopi…
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: A Study to Test the Long-term Safety of BI 655130 in Patients With Atopic Eczema Who Took Part in Study 1368-0032 [Phase 2]
Long-term safety data from a Phase 2 study of BI 655130 in patients with atopic dermatitis; the trial was terminated and results were posted…
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: A Clinical Study of Adherence to Methylprednisolone Aceponate in Different Carriers [Phase 4]
Phase 4 clinical study evaluating adherence to methylprednisolone aceponate in different carriers for chronic eczema.
-
CLINICAL_TRIALS trial_result · 2022-05-06Clinical Trial Update: Efficacy and Safety of Orally Administered DS107 in Adult Patients With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 trial of DS107 for adults with moderate to severe atopic dermatitis was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-05-02Clinical Trial Update: Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis. [Phase 3]
Phase 3 trial evaluating lebikizumab with topical corticosteroid in moderate-to-severe atopic dermatitis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-05-02Clinical Trial Update: Crisaborole for Chinese and Japanese Subjects (≥2 Years of Age) With Mild to Moderate Atopic Dermatitis [Phase 3]
Phase 3 trial update for Crisaborole in Chinese and Japanese children aged ≥2 with mild to moderate atopic dermatitis completed; results pos…